Mylan Makes Decision On Potential First Botox Biosimilar

Launch In US By 2025 Has Been Mooted

 
• By Dean Rudge
  
Young adult woman walking up the stairs with sun sport background.
Mylan will progress with plans to develop biosimilar Botox with Revance • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products